Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASHLAND INC.ASH · Entity 4139 | Director | January 24, 2023 | January 26, 2023 |
| Celanese CorpCE · Entity 3922 | Director | March 10, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASHLAND INC.
Report date January 24, 2023 · Filed January 26, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,043 |
Reported balance
After 2023-01-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-24 · Grant · Acquired 1,365 · Balance 10,043 F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock. F3: Balance includes 8678 Restricted Stock Units mandatorily deferred pursuant to the Ashland's Deferred Compensation Plan for Non-Employee Directors. Balance also includes 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 31 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 29 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
F2: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock.
F3: Balance includes 8678 Restricted Stock Units mandatorily deferred pursuant to the Ashland's Deferred Compensation Plan for Non-Employee Directors. Balance also includes 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 31 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 29 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022.
Celanese Corp
Report date March 10, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 10,241.119 |
Reported balance
After 2026-03-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-10 · Grant · Acquired 6.06 · Balance 10,241.119 F1: Each share of phantom stock represents the right to receive one share of Common Stock. F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock represents the right to receive one share of Common Stock.
F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2026 Filed Mar 11, 2026 16:42 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 6.06 | $50.67 | $307.06 |
DisclosureSEC source: 0001306830-26-000064 · wk-form4_1773261759.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,241.119 Underlying: Common Stock · 6.06 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 16:22 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 7.84 | $39.12 | $306.70 |
DisclosureSEC source: 0001306830-25-000235 · wk-form4_1763068929.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,235.059 Underlying: Common Stock · 7.84 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 16:24 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 6.47 | $47.42 | $306.81 |
DisclosureSEC source: 0001306830-25-000184 · wk-form4_1755116653.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,227.219 Underlying: Common Stock · 6.47 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 12, 2025 Filed May 13, 2025 16:21 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 5.62 | $54.53 | $306.46 |
DisclosureSEC source: 0001306830-25-000117 · wk-form4_1747167652.xml · derivative · entry 2 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,220.749 Underlying: Common Stock · 5.62 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F3 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F3 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 09, 2025 Filed May 13, 2025 16:21 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 3,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-25-000117 · wk-form4_1747167652.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,850 F1 · shares: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 16:11 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 5.61 | $54.61 | $306.36 |
DisclosureSEC source: 0001306830-25-000062 · wk-form4_1741896692.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,215.129 Underlying: Common Stock · 5.61 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 16:21 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 95.67 | $74.00 | $7,079.58 |
DisclosureSEC source: 0001306830-24-000192 · wk-form4_1731705691.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,209.519 Underlying: Common Stock · 95.67 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 16:42 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 56.237 | $125.19 | $7,040.31 |
DisclosureSEC source: 0001306830-24-000163 · wk-form4_1723668158.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,113.849 Underlying: Common Stock · 56.237 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 15, 2024 Filed May 17, 2024 16:36 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,114 | $156.96 | $174,853.44 |
DisclosureSEC source: 0001306830-24-000134 · wk-form4_1715978157.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,474 F1 · shares: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| May 13, 2024 Filed May 14, 2024 17:25 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 43.745 | $160.24 | $7,009.70 |
DisclosureSEC source: 0001306830-24-000115 · wk-form4_1715721903.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,057.612 Underlying: Common Stock · 43.745 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 16:46 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 46.023 | $151.61 | $6,977.55 |
DisclosureSEC source: 0001306830-24-000062 · wk-form4_1709847947.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,013.867 Underlying: Common Stock · 46.023 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 16:16 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 58.857 | $117.85 | $6,936.30 |
DisclosureSEC source: 0001306830-23-000173 · wk-form4_1700082999.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,967.844 Underlying: Common Stock · 58.857 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 16:39 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 55.49 | $124.30 | $6,897.41 |
DisclosureSEC source: 0001306830-23-000138 · wf-form4_169213196437084.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,908.987 Underlying: Common Stock · 55.49 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 15, 2023 Filed May 16, 2023 16:33 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 65.119 | $105.22 | $6,851.82 |
DisclosureSEC source: 0001306830-23-000107 · wf-form4_168426917078671.xml · derivative · entry 3 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,853.497 Underlying: Common Stock · 65.119 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F3 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F3 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 12, 2023 Filed May 16, 2023 16:33 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,777 | $98.46 | $174,963.42 |
DisclosureSEC source: 0001306830-23-000107 · wf-form4_168426917078671.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,360 F1 · shares: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| March 07, 2023 Filed May 16, 2023 16:33 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 57.885 | $117.67 | $6,811.33 |
DisclosureSEC source: 0001306830-23-000107 · wf-form4_168426917078671.xml · derivative · entry 2 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,788.378 Underlying: Common Stock · 57.885 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F3 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F3 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 22:31 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,365 | $109.85 | $149,945.25 |
DisclosureSEC source: 0001127602-23-002335 · form4.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,043 Underlying: Common Stock · 1,365 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock. F2 · derivative.expiration_date: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock. F3 · balance_after: Balance includes 8678 Restricted Stock Units mandatorily deferred pursuant to the Ashland's Deferred Compensation Plan for Non-Employee Directors. Balance also includes 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 31 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 29 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 21:28 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 64.44 | $105.00 | $6,766.20 |
DisclosureSEC source: 0001306830-22-000195 · wf-form4_166865206818326.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,730.493 Underlying: Common Stock · 64.44 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 16:35 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 58.86 | $110.99 | $6,532.87 |
DisclosureSEC source: 0001306830-22-000155 · wf-form4_166007729734254.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,666.053 Underlying: Common Stock · 58.86 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 12, 2022 Filed May 16, 2022 17:21 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 46.764 | $139.02 | $6,501.13 |
DisclosureSEC source: 0001306830-22-000126 · wf-form4_165273606333708.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,607.193 Underlying: Common Stock · 46.764 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 03, 2022 Filed May 5, 2022 16:49 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,098 | $145.68 | $159,956.64 |
DisclosureSEC source: 0001306830-22-000112 · wf-form4_165178375924733.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,583 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 17:22 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 48.307 | $133.90 | $6,468.31 |
DisclosureSEC source: 0001306830-22-000069 · wf-form4_164695092083779.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,560.429 Underlying: Common Stock · 48.307 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| January 24, 2022 Filed Jan 25, 2022 21:58 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,139 | $96.61 | $110,038.79 |
DisclosureSEC source: 0001127602-22-002070 · form4.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,553 Underlying: Common Stock · 1,139 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · balance_after: Balance includes 27 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2021; 26 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2021; 27 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2021; 25 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2021. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 17:14 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 38.479 | $167.42 | $6,442.15 |
DisclosureSEC source: 0001306830-21-000217 · wf-form4_163710083868914.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,512.122 Underlying: Common Stock · 38.479 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:36 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 40.985 | $156.50 | $6,414.15 |
DisclosureSEC source: 0001306830-21-000173 · wf-form4_162871417632605.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,473.643 Underlying: Common Stock · 40.985 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:19 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 38.207 | $167.20 | $6,388.21 |
DisclosureSEC source: 0001306830-21-000134 · wf-form4_162085074962255.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,432.658 Underlying: Common Stock · 38.207 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 16:15 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 975 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-21-000113 · wf-form4_161972729980317.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,485 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 16:20 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 46.413 | $136.96 | $6,356.72 |
DisclosureSEC source: 0001306830-21-000059 · wf-form4_161428798751272.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,394.451 Underlying: Common Stock · 46.413 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:47 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002815 · form4.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,309 Underlying: Common Stock · 1,319 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · balance_after: Balance includes 27 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2020; 28 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2020; 25 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2020; 25 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2020. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 16:17 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 45.103 | $127.88 | $5,767.77 |
DisclosureSEC source: 0001306830-20-000214 · wf-form4_160530222279282.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,348.038 Underlying: Common Stock · 45.103 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 16:15 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 57.916 | $98.97 | $5,731.95 |
DisclosureSEC source: 0001306830-20-000175 · wf-form4_159709051571054.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302.935 Underlying: Common Stock · 57.916 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 07, 2020 Filed May 8, 2020 16:13 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 70.791 | $80.35 | $5,688.06 |
DisclosureSEC source: 0001306830-20-000139 · wf-form4_158896877143499.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,245.019 Underlying: Common Stock · 70.791 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| April 30, 2020 Filed May 4, 2020 16:20 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-20-000126 · wf-form4_158862361656211.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,510 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 16:07 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 60.28 | $93.74 | $5,650.65 |
DisclosureSEC source: 0001306830-20-000066 · wf-form4_158318323132015.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,174.228 Underlying: Common Stock · 60.28 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 21:42 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,449 | $75.90 | $109,979.10 |
DisclosureSEC source: 0001127602-20-003174 · form4.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,226 Underlying: Common Stock · 1,449 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · balance_after: Balance includes 15 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2019, 16 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2019, 16 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2019, and 18 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2019. Read SEC document |
| January 30, 2020 Filed Feb 11, 2020 20:25 UTC Amendment | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 2,108 | $75.90 | $159,997.20 |
DisclosureSEC source: 0001127602-20-004843 · form4a.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,885 Underlying: Common Stock · 2,108 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock. F2 · shares: Due to administrative error, an incorrect number of RSUs was reported. Actual RSUs granted were 2,108 with same grant date and same grant price as previously disclosed. F3 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.underlying_shares: Due to administrative error, an incorrect number of RSUs was reported. Actual RSUs granted were 2,108 with same grant date and same grant price as previously disclosed. F4 · balance_after: Balance includes 15 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2019, 16 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2019, 16 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2019, and 18 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2019. Read SEC document |
| November 07, 2019 Filed Nov 12, 2019 16:07 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 44.719 | $125.74 | $5,622.97 |
DisclosureSEC source: 0001306830-19-000201 · wf-form4_157359282954569.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,113.948 Underlying: Common Stock · 44.719 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 16:07 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 54.166 | $103.19 | $5,589.39 |
DisclosureSEC source: 0001306830-19-000175 · wf-form4_156512203622066.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,069.229 Underlying: Common Stock · 54.166 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 09, 2019 Filed May 13, 2019 16:09 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 53.63 | $103.60 | $5,556.07 |
DisclosureSEC source: 0001306830-19-000140 · wf-form4_155777816100997.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,015.063 Underlying: Common Stock · 53.63 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 16:14 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-19-000117 · wf-form4_155656885294931.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,661 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| April 20, 2019 Filed Apr 23, 2019 16:41 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 1,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-19-000096 · wf-form4_155605203862574.xml · derivative · entry 2 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,961.433 Underlying: Common Stock · 1,372 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F3 · derivative.exercise_date: As provided in the 2008 Deferred Compensation Plan, the reported phantom stock becomes payable in shares of Common Stock upon termination of the reporting person's service as a director of the Company subject to certain restrictions and limitations. F3 · derivative.expiration_date: As provided in the 2008 Deferred Compensation Plan, the reported phantom stock becomes payable in shares of Common Stock upon termination of the reporting person's service as a director of the Company subject to certain restrictions and limitations. Read SEC document |
| April 20, 2019 Filed Apr 23, 2019 16:41 UTC | Celanese Corp CE · Entity 3922 | Disposition to issuerCommon Stock | 1,372 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001306830-19-000096 · wf-form4_155605203862574.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,257 F1 · price: Upon vesting of 1,372 Restricted Stock Units granted to the reporting person on April 20, 2018, the reporting person deferred the receipt of 1,372 shares of Common Stock and received instead 1,372 shares of phantom stock pursuant to the Company's 2008 Deferred Compensation Plan. As a result, the reporting person is reporting the disposition of 1,372 shares of Common Stock in exchange for an equal number of shares of phantom stock. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:11 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 39.658 | $102.80 | $4,076.84 |
DisclosureSEC source: 0001306830-19-000057 · wf-form4_155182027693821.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,589.433 Underlying: Common Stock · 39.658 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 20:18 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,413 | $77.85 | $110,002.05 |
DisclosureSEC source: 0001127602-19-005329 · form4.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,709 Underlying: Common Stock · 1,413 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.expiration_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · balance_after: Balance includes 10 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2018, 10 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2018, 10 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2018 and 11 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2018, pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, exempt under Rule 16b-3. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 08:43 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 38.658 | $104.92 | $4,056.00 |
DisclosureSEC source: 0001306830-18-000251 · wf-form4_154211662316927.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,549.775 Underlying: Common Stock · 38.658 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 06, 2018 Filed Aug 7, 2018 16:30 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 34.625 | $116.60 | $4,037.28 |
DisclosureSEC source: 0001306830-18-000185 · wf-form4_153367379436462.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511.117 Underlying: Series A Common Stock · 34.625 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 10, 2018 Filed May 14, 2018 17:10 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 36.656 | $109.60 | $4,017.50 |
DisclosureSEC source: 0001306830-18-000142 · wf-form4_152633223419357.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,476.492 Underlying: Series A Common Stock · 36.656 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 16:43 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-18-000125 · wf-form4_152460254865737.xml · derivative · entry 3 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,439.836 Underlying: Series A Common Stock · 1,601 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F4 · derivative.exercise_date: As provided in the 2008 Deferred Compensation Plan, on the earlier date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company, the reported phantom stock becomes payable in shares of Series A Common Stock subject to certain limitations. F4 · derivative.expiration_date: As provided in the 2008 Deferred Compensation Plan, on the earlier date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company, the reported phantom stock becomes payable in shares of Series A Common Stock subject to certain limitations. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 16:43 UTC | Celanese Corp CE · Entity 3922 | Disposition to issuerSeries A Common Stock | 1,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001306830-18-000125 · wf-form4_152460254865737.xml · nonDerivative · entry 2 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,629 F2 · price: Upon vesting of 1,601 Restricted Stock Units granted to the reporting person on April 20, 2017, the reporting person deferred the receipt of 1,601 shares of Series A Common Stock and received instead 1,601 shares of phantom stock pursuant to the Company's 2008 Deferred Compensation Plan. As a result, the reporting person is reporting the disposition of 1,601 shares of Series A Common Stock in exchange for an equal number of shares of phantom stock. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 16:43 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-18-000125 · wf-form4_152460254865737.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,230 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as amended and restated. The restricted stock units vest in full on the one-year anniversary of the date of the grant. The reporting person has elected that upon vesting of the restricted stock units, receipt of the shares of Series A Common Stock be deferred under the Company's 2008 Deferred Compensation Plan; accordingly, upon vesting, the reporting person will instead receive an equal number of shares of phantom stock. As provided in the Company's 2008 Deferred Compensation Plan, the phantom stock becomes payable in shares of Series A Common Stock upon the earlier of the date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.